Correlation between the CD4 cell counts and the pathogenesis and treatment of bronchial asthma.

Correlation between the CD4 cell counts and the pathogenesis and treatment of bronchial asthma. - Correlation between the CD4 cell counts and bronchial asthma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023817

Enrollment

Registered

2016-10-10

Start date

2016-10-10

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection Bronchial Asthama

Interventions

Inhaled corticosteroid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1.Presence of a known pre-existing, clinically important lung condition. This includes current infection or a history of cancer. 2.Subjects can not read, comprehend,and write at a level sufficient to complete study related materials. 3.Severe bronchial asthma 4.Subjects who are pregnant or breastfeeding. 5.HIV virus was infected by blood components.

Design outcomes

Primary

Measure	Time frame
1.Comobidity of bornchial asthma or atopic dermatitis in HIV positive patients. 2. To clarify the efficacy and safety of inhaled corticosteroids.	—

Secondary

Measure	Time frame
1-1. To discover the factor attribute to bronchial asthma onset. 1-2. To evaluate the correlation between airway hyper-responsiveness and lung function and CD4 cell counts. 2-1. Can inhaled corticosteroid reduce the frequency of SABA inhaler use. 2-2. To clarify the correlation between CD4 cell counts and asthma therapy.	—

Countries

Japan

Contacts

Public ContactMasaki Tominaga

Kurume University School of Medicine Division of Respirology, Neurology and rheumatology, Department of Medicine 1

tominaga_masaki@med.kurume-u.ac.jp0942-31-7560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026